Agilent Technologies Inc. is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward advancing the quality of life.
- Booth: D208
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Booth: A201
Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd. is a pioneer and globally leading company in the field of molecular diagnostics for precision oncology, focusing on companion diagnostics product development and commercialization.
- Booth: C208
Astellas Pharma Europe Ltd.
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people around the world.
- Booth: D201
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients.
AstraZeneca has the vision to redefine cancer care and one day eliminate cancer as a cause of death.
- Booth: A101
BeiGene Singapore Pte Ltd
BeiGene is a science-driven biotechnology company operating across five continents. We are focused on developing innovative and affordable cancer medicines to improve treatment outcomes and access for 2 billion more people worldwide by 2030.
- Booth: F101
Boehringer Ingelheim Singapore Pte. Ltd.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need.
- Booth: D101
Boston Scientific Asia Pacific Pte Ltd
Boston Scientific is a global medical technology leader. For over 40 years, we have advanced science for life by providing a broad range of innovative, high performance solutions to address unmet patient needs and reduce the cost of healthcare.
- Booth: G106
Dr. Reddy’s Laboratories Limited
Dr.Reddy’s Laboratories is an integrated global biopharmaceutical company with research and development centers, manufacturing facilities or a commercial presence in 66 countries with 24000 plus employees.
- Booth: D205
Eisai Co., Ltd.
Eisai’s philosophy is summarized by the term “human health care (hhc)”. In alignment with this, Eisai Asia Region is devoted to continuously improve access to Eisai’s innovative cancer drugs through innovative access programs and science-based activities across Asia.
- Booth: C201
Everest Pharmaceuticals Limited
Everest Pharmaceuticals is one of the most innovative emerging pharmaceutical company in Bangladesh that manufactures world generic version of anticancer , antiviral and Hematology products at the cost effective prices.
- Booth: C205
F. Hoffmann-La Roche Ltd
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.
Roche’s truly differentiated medicines and personalised healthcare strategy aims at enabling tangible improvements in the lives of patients.
- Booth: C101
Gilead Sciences Singapore Pte. Ltd.
Gilead and Kite Oncology are creating the future of oncology. From ADCs and small molecules to cell therapy, our R&D programs and partnerships are focused on helping to bring more life to people with cancer and changing the way cancer is treated.
- Booth: C202
GlaxoSmithKline Pte Ltd
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.
Guardant Health AMEA
Guardant Health Asia, Middle East & Africa is a leading precision oncology company focused on helping conquer cancer globally through use of proprietary blood tests, vast data sets and advanced analytics. Our mission is to conquer cancer with data.
- Booth: A401
Hetero is a pharmaceutical player engaged in R&D, manufacturing, and marketing of chemical and biologic drugs across diverse therapeutic areas. Its strategic business areas include APIs, Generics, Biosimilars and Custom Pharmaceutical Services.
- Booth: C206
Hi-Q Marine Biotech International Ltd
Hi-Q (Taiwan) specializes in the research and development of Low Molecular Weight Fucoidan (Oligo Fucoidan), clinically-proven ingredient used as a nutritional adjunct for cancer patients, provides nutritional therapy to improve the quality of life.
- Booth: A402
Ipsen is a global biopharmaceutical company focused on transformative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases.
Date of prep: June 2022
- Booth: E101
We’re Janssen, the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science. At Janssen, we're creating a future where disease is a thing of the past.
- Booth: G101
Juniper Biologics is focused on creating access to the next generation of life-changing medicines in Oncology, Rare/Orphan Diseases and Gene Therapy for patient communities in China, Japan, Asia, Australia, New Zealand, the Middle East and Africa.
- Booth: G105
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. is a Japan-based global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology.
- Booth: D206
Lucence invents ultrasensitive liquid biopsy tests to provide cancer patients with reliable genomic profiling from screening to diagnosis to monitoring.
- Booth: E207
Medpace is a global, full-service clinical contract research organization providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries with deep therapeutic expertise across all major areas.
- Booth: C211
Merck Healthcare KGaA
Merck KGaA, Darmstadt, Germany is a science-led organization dedicated to making a meaningful difference in the lives of people affected by cancer.
- Booth: E201
MGI Tech focuses on R&D, production and sales of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine, precision healthcare and other relevant industries.
- Booth: C209
Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women’s health, oncology, and organ health.
- Booth: C210
Pfizer Pte Ltd
At Pfizer, we apply science and global resources to advance wellness, prevention, treatments and cures. We work to support access to reliable, affordable healthcare around the world.
Our purpose is clear: deliver breakthroughs that change patients’ lives.
- Booth: A301
Pierre Fabre is the 2nd largest private French pharmaceutical group and the market leader in France for products sold in pharmacies. Its portfolio includes several medical franchises including oncology. Its products are sold in about 130 countries.
Seagen is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development.
- Booth: E205
Servier has made oncology one of its foremost priorities, focusing on hard-to-treat cancers. To date 23 projects in the oncology field are clinical development, balanced between monoclonal antibodies and targeted small molecules.
- Booth: C207
Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. Our Mission is to make the world healthier, cleaner & safer by accelerating life sciences research, solving complex analytical challenges & improving patient diagnostics & therapies.
- Booth: E206